NCT00315861View on ClinicalTrials.gov

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

January 31, 2009

Conditions

Ovarian CancerEndometrial CancerCervical CancerLung Cancer

Interventions

DRUG

pemetrexed

DRUG

topotecan

Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER